Patents by Inventor Fredric D. Price

Fredric D. Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180256582
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 13, 2018
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Patent number: 9993481
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: June 12, 2018
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Publication number: 20160367558
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Application
    Filed: September 2, 2016
    Publication date: December 22, 2016
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Patent number: 9433624
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: September 6, 2016
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Publication number: 20120108599
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 3, 2012
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Patent number: 8067416
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: November 29, 2011
    Assignees: Merck Eprova AG, Biomarin Pharmaceutical Inc.
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Publication number: 20100009996
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Application
    Filed: July 23, 2009
    Publication date: January 14, 2010
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Patent number: 7566714
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: July 28, 2009
    Assignee: Biomarin Pharmaceutical Inc.
    Inventors: Daniel I. Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum, Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Publication number: 20080090832
    Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
    Type: Application
    Filed: October 2, 2006
    Publication date: April 17, 2008
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Daniel Oppenheimer, Emil D. Kakkis, Fredric D. Price, Alejandro Dorenbaum
  • Patent number: 6713469
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: March 30, 2004
    Assignee: Ambi Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Publication number: 20020197340
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Application
    Filed: July 25, 2002
    Publication date: December 26, 2002
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6471998
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: October 29, 2002
    Assignee: Ambi, Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6432942
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: August 13, 2002
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6323192
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: November 27, 2001
    Assignee: Ambi Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Publication number: 20010036490
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Application
    Filed: May 4, 2001
    Publication date: November 1, 2001
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Publication number: 20010016580
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Application
    Filed: May 4, 2001
    Publication date: August 23, 2001
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6251889
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: June 26, 2001
    Assignee: AMBI, Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6251888
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: June 26, 2001
    Assignee: Ambi, Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6143301
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: November 7, 2000
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6136317
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: October 24, 2000
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth